Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth.
While accumulating evidence has shown that the use of the diabetic drug metformin may be beneficial against various tumors in some epidemiological studies, a few studies failed to show the same beneficial effects. The molecular and cellular mechanisms for these conflicting observations are not clear...
Main Authors: | Hua Yang, Yuan-Fei Peng, Hong-Min Ni, Yuan Li, Ying-Hong Shi, Wen-Xing Ding, Jia Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4482411?pdf=render |
Similar Items
-
Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma
by: Wei Zhao, et al.
Published: (2022-08-01) -
Realgar facilitates the Nrf2-Keap1-p62 positive feedback signaling axis via MAPKs and AKT to interfere with autophagy-induced apoptosis and oxidative stress in the hippocampus
by: Yuan Meng, et al.
Published: (2022-06-01) -
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
by: José A Del Campo, et al.
Published: (2018-01-01) -
Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
by: Heloisa P Soares, et al.
Published: (2013-01-01) -
Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway
by: Hong Qiao, et al.
Published: (2018-06-01)